337 related articles for article (PubMed ID: 20442301)
1. A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo.
Harikumar KB; Kunnumakkara AB; Ochi N; Tong Z; Deorukhkar A; Sung B; Kelland L; Jamieson S; Sutherland R; Raynham T; Charles M; Bagherzadeh A; Foxton C; Boakes A; Farooq M; Maru D; Diagaradjane P; Matsuo Y; Sinnett-Smith J; Gelovani J; Krishnan S; Aggarwal BB; Rozengurt E; Ireson CR; Guha S
Mol Cancer Ther; 2010 May; 9(5):1136-46. PubMed ID: 20442301
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase D1 promotes anchorage-independent growth, invasion, and angiogenesis by human pancreatic cancer cells.
Ochi N; Tanasanvimon S; Matsuo Y; Tong Z; Sung B; Aggarwal BB; Sinnett-Smith J; Rozengurt E; Guha S
J Cell Physiol; 2011 Apr; 226(4):1074-81. PubMed ID: 20857418
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase d as a potential chemotherapeutic target for colorectal cancer.
Wei N; Chu E; Wipf P; Schmitz JC
Mol Cancer Ther; 2014 May; 13(5):1130-41. PubMed ID: 24634417
[TBL] [Abstract][Full Text] [Related]
4. A novel protein kinase D inhibitor attenuates early events of experimental pancreatitis in isolated rat acini.
Thrower EC; Yuan J; Usmani A; Liu Y; Jones C; Minervini SN; Alexandre M; Pandol SJ; Guha S
Am J Physiol Gastrointest Liver Physiol; 2011 Jan; 300(1):G120-9. PubMed ID: 20947701
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M.
Li QQ; Hsu I; Sanford T; Railkar R; Balaji N; Sourbier C; Vocke C; Balaji KC; Agarwal PK
Cell Mol Life Sci; 2018 Mar; 75(5):939-963. PubMed ID: 29071385
[TBL] [Abstract][Full Text] [Related]
6. PKD, PKD2, and p38 MAPK mediate Hsp27 serine-82 phosphorylation induced by neurotensin in pancreatic cancer PANC-1 cells.
Yuan J; Rozengurt E
J Cell Biochem; 2008 Feb; 103(2):648-62. PubMed ID: 17570131
[TBL] [Abstract][Full Text] [Related]
7. Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells.
Hao F; Xu Q; Zhao Y; Stevens JV; Young SH; Sinnett-Smith J; Rozengurt E
Mol Cancer Res; 2017 Jul; 15(7):929-941. PubMed ID: 28360038
[TBL] [Abstract][Full Text] [Related]
8. SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest.
Tandon M; Salamoun JM; Carder EJ; Farber E; Xu S; Deng F; Tang H; Wipf P; Wang QJ
PLoS One; 2015; 10(3):e0119346. PubMed ID: 25747583
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase d regulates cell death pathways in experimental pancreatitis.
Yuan J; Liu Y; Tan T; Guha S; Gukovsky I; Gukovskaya A; Pandol SJ
Front Physiol; 2012; 3():60. PubMed ID: 22470346
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
11. Novel Small Molecule Inhibitors of Protein Kinase D Suppress NF-kappaB Activation and Attenuate the Severity of Rat Cerulein Pancreatitis.
Yuan J; Tan T; Geng M; Tan G; Chheda C; Pandol SJ
Front Physiol; 2017; 8():1014. PubMed ID: 29270134
[TBL] [Abstract][Full Text] [Related]
12. The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer.
Liu Y; Wang Y; Yu S; Zhou Y; Ma X; Su Q; An L; Wang F; Shi A; Zhang J; Chen L
Cell Physiol Biochem; 2019; 52(3):382-396. PubMed ID: 30845378
[TBL] [Abstract][Full Text] [Related]
13. New pyrazolopyrimidine inhibitors of protein kinase d as potent anticancer agents for prostate cancer cells.
Tandon M; Johnson J; Li Z; Xu S; Wipf P; Wang QJ
PLoS One; 2013; 8(9):e75601. PubMed ID: 24086585
[TBL] [Abstract][Full Text] [Related]
14. Role of protein kinase D signaling in pancreatic cancer.
Guha S; Tanasanvimon S; Sinnett-Smith J; Rozengurt E
Biochem Pharmacol; 2010 Dec; 80(12):1946-54. PubMed ID: 20621068
[TBL] [Abstract][Full Text] [Related]
15. Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.
Radhakrishnan P; Bryant VC; Blowers EC; Rajule RN; Gautam N; Anwar MM; Mohr AM; Grandgenett PM; Bunt SK; Arnst JL; Lele SM; Alnouti Y; Hollingsworth MA; Natarajan A
Clin Cancer Res; 2013 Apr; 19(8):2025-35. PubMed ID: 23444213
[TBL] [Abstract][Full Text] [Related]
16. Target therapy using a small molecule inhibitor against angiogenic receptors in pancreatic cancer.
Büchler P; Reber HA; Roth MM; Shiroishi M; Friess H; Hines OJ
Neoplasia; 2007 Feb; 9(2):119-27. PubMed ID: 17356708
[TBL] [Abstract][Full Text] [Related]
17. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
[TBL] [Abstract][Full Text] [Related]
18. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
[TBL] [Abstract][Full Text] [Related]
19. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1.
Guha S; Rey O; Rozengurt E
Cancer Res; 2002 Mar; 62(6):1632-40. PubMed ID: 11912133
[TBL] [Abstract][Full Text] [Related]
20. Induced overexpression of protein kinase D1 stimulates mitogenic signaling in human pancreatic carcinoma PANC-1 cells.
Kisfalvi K; Hurd C; Guha S; Rozengurt E
J Cell Physiol; 2010 May; 223(2):309-16. PubMed ID: 20082306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
